Development and Evaluation of Mobile App Based Myofunctional Therapy Program (MabMTP) in Obstructive Sleep Apnea: An Intervention Mapping Approach

Not Applicable

Completed

• Conditions: Diseases of the nervous system

• Registration Number: KCT0008472
• Lead Sponsor: Pusan National University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2024-05-08
• Last Update Posted: 23 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

Inclusion Criteria
Individuals who understand the purpose of this study and agree to participate.
Individuals diagnosed with obstructive sleep apnea by a sleep specialist based on the results of a sleep study, and who have been recommended myofunctional therapy by the sleep specialist.
Adults aged 18 years or older.
Individuals with no communication disabilities.
Individuals who can attach the sleep study device to at least one finger and wrist.
Individuals who have a mobile phone capable of running the mobile app (Android or iOS) and can use it without assistance.

Exclusion Criteria

Exclusion Criteria
Individuals with severe nasal obstruction or facial deformities confirmed by imaging studies.
Individuals whom the sleep specialist determines to be unable to perform myofunctional therapy due to musculoskeletal disorders.
Individuals with autonomic nervous system dysfunction, peripheral neuropathy, vascular disease, heart disease, or lung disease.
Individuals taking medications that may affect peripheral arterial tone (adrenergic blockers).
Types of adrenergic blockers: Tolazoline, Trazodone, Phenoxybenzamine, Phentolamine, Doxazosin, Silodosin, Alfuzosin, Tamsulosin, Terazosin, Prazosin, Mirtazapine, Atipamezole, Yohimbine, Idazoxan, Labetalol, Carvedilol.
(Note: Criteria 3 and 4 are exclusion criteria to prevent errors that may occur when using portable sleep study devices.)

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
apnea-hypopnea index

Secondary Outcome Measures

Name	Time	Method
daytime sleepiness, sleep quality, self-efficacy, outcome expectancy, intervention adherence, lowest spo2, snoring rate